Christophe Deroose
@deroose_c
Professor Nuclear Medicine. UZ leuven - KU Leuven. Cycling lover. Views expressed are my own. ♥️🇺🇦. No to war!
You might like
More on bone metastases in patients with NENs... 320 patients from 18 Italian centers, mostly well/mod diff NETs. Interestingly, bone was the first site of mets in 41%. mOS was 62 months and SREs observed in 22% and 31% of patients received antiresorptive therapy. Primary lung…
LRRC15 at the crossroads: Radioimmunotherapy charts a potential path forward. ow.ly/9uGV50XqItn #NuclearMedicine #RPTherapy #PersonalizedMedicine @sartor_oliver
A timeline of multimodality imaging. ow.ly/1oSq50XqrcQ #NuclearMedicine #MedicalImaging #PETscan
RECIP criteria applied on C2 24h Lu-PSMA SPECT/CT is an independent prognostic tool for early identification of patients unlikely to benefit from PSMA-RLT. Thanks to all the NucMed team at @JulesBordet specially to our PhD Fellow Dr M. Kassas. #PSMA #RECIP link.springer.com/article/10.100…
[68Ga]Ga-DPI-4452 PET/CT for staging of patients with clear cell renal cell carcinoma #ESMO25
![dralvaropinto's tweet image. [68Ga]Ga-DPI-4452 PET/CT for staging of patients with clear cell renal cell carcinoma #ESMO25](https://pbs.twimg.com/media/G3m4JNCXUAAVfkH.jpg)
![dralvaropinto's tweet image. [68Ga]Ga-DPI-4452 PET/CT for staging of patients with clear cell renal cell carcinoma #ESMO25](https://pbs.twimg.com/media/G3m4JNCWIAAzvXM.jpg)
![dralvaropinto's tweet image. [68Ga]Ga-DPI-4452 PET/CT for staging of patients with clear cell renal cell carcinoma #ESMO25](https://pbs.twimg.com/media/G3m4JM_WIAAU0Ak.jpg)
![dralvaropinto's tweet image. [68Ga]Ga-DPI-4452 PET/CT for staging of patients with clear cell renal cell carcinoma #ESMO25](https://pbs.twimg.com/media/G3m4JNCW8AA_Awi.jpg)
There’s still time to take part in our two ongoing EANM surveys. Your input is essential to guide future developments and priorities in our field. 🔹 AI Survey 🔹 Optical Imaging Survey 📅 Deadline: October 15, 2025 🔗 eanm.org/publications/u… Thank you for taking part!
🔥 LUNAR trial: In oligometastatic hormone-sensitive #ProstateCancer, adding 2 cycles of 177Lu-PSMA 💥 ☢️ before SBRT ⬆️ doubled PFS (18 vs 7 mo, HR 0.32, p<0.001) with minimal added adverse events. 🚀 PSMA-RLT + SBRT = new frontier #ASTRO25 #RadOnc #NuclearMedicine @ASTRO_org
The marriage of the century. EARL, ARTnet and CTN officially sign historical MOU on global PET harmonization program. Follow for more details. #eanm25 #snmmi #artnet
Let’s Unite to Fight Cancer! 💪 Ten years ago, we made history with Australia’s first-ever Lutetium-PSMA treatment - research that’s changed prostate cancer care worldwide. Since then, our team has led 10+ clinical trials, bringing cutting-edge science straight to patients and…
#eanm25 Maximizing PSMA Theranostics? Grace Kong from @PeterMacCC with a fantastic journey of Australian on going trials. Combinations with ARPIs, chemo, inmuno, radiotherapy, alpha and many more!! @DrMHofman @urotoday @pros_tic @dandanmena @sepsis000 @julired3
Happening now at @EANM_NucMed in Barcelona! 🚀 EORTC is part of this morning’s Joint Symposium session diving into PET response criteria: beyond RECIST, EORTC & PERCIST. 🕗 08:00–09:30 CEST ➡️ More info: eanm25.eanm.org/programme-info… #EANM25 #Oncology #Theranostics #CancerResearch
Great session @ #EANM2025 on PET response criteria, from FDG EORTC/PERCIST to Lugano/Impetus, PSMA and SSTR PET. Joint session by @EANM_NucMed and @EORTC.
Congratulations to Emmanuel Deshayes for receiving the #MarieCurieAward for his abstract 'Dosimetry of [177Lu]Lu-edotreotide in patients with grade 1 or grade 2 gastroenteropancreatic neuroendocrine tumours: Results from the COMPETE Phase 3 trial'. 👏 © Faistauer Photography
![EANM_NucMed's tweet image. Congratulations to Emmanuel Deshayes for receiving the #MarieCurieAward for his abstract 'Dosimetry of [177Lu]Lu-edotreotide in patients with grade 1 or grade 2 gastroenteropancreatic neuroendocrine tumours: Results from the COMPETE Phase 3 trial'. 👏
© Faistauer Photography](https://pbs.twimg.com/media/G2gVtrGW4AAMBNk.jpg)
Get ready for Day 2 🚀 We hope you had the chance to reconnect with colleagues and friends! Here are tomorrow’s top picks you won’t want to miss 👇 For any questions, reach us at [email protected] or stop by the Registration Desk — we’re happy to help!
In our discussion with @helops79 and @ProfKHerrmann, we touched on the role of PRRT in NETs. A few key studies to keep in mind (⬆️PFS): - #COMPETE - #COMPOSE - #NETTER1 - #NETTER2 #OncTwitter #MedTwitter #gism
PRRT - Radioligand Rx options in Neuroendocrine Tumors (NETs) with @helops79 & Ken Herrmann ✅ Different molecules ✅ Squencing ✅ Scans Full discussion: oncbrothers.com/net-prrt-2025 - m.youtube.com/watch?si=mYVB6… - Also on the “Oncology Brothers” podcast #OncTwitter #MedTwitter
🚨Online today: Prognostic and predictive value of baseline PSMA-PET total tumour volume and SUVmean in metastatic castration-resistant #prostatecancer in #ENZAp (ANZUP1901): a substudy from a multicentre, open-label, randomised, phase 2 trial thelancet.com/journals/lanon…
Foregoing Nonclinical Dosimetry Studies to Support First-in-Human Studies of Certain PET Radiopharmaceuticals | Journal of Nuclear Medicine jnm.snmjournals.org/content/early/…
Exciting news on the #EANMJournals! 🆕 #EANM now has 2 dedicated open-access journals published by @ElsevierConnect: 🔹 The EANM Journal 🔹 EANM Innovation 🔗 Find out more: eanm.org/news/eanm-jour… We look forward to the next steps. Stay tuned! #NuclearMedicine
¹⁷⁷Lu-DOTATATE is cost-effective as a first-line treatment for patients with grade 2 or 3, well-differentiated, advanced gastroenteropancreatic #NeuroendocrineTumors. ow.ly/Zzw150W9YMP #NuclearMedicine @WolfgangGKunzMD @MUnterrainerMD @matbrendel @UnterrainerLena
United States Trends
- 1. Bryce 10.3K posts
- 2. Panthers 21.9K posts
- 3. Jaycee Horn N/A
- 4. Purdy 5,161 posts
- 5. #KeepPounding 3,555 posts
- 6. 49ers 24.7K posts
- 7. Syracuse 6,333 posts
- 8. #FTTB 2,932 posts
- 9. Melo 14.1K posts
- 10. Comey 208K posts
- 11. GeForce Season 4,597 posts
- 12. Mark Kelly 143K posts
- 13. Jauan Jennings N/A
- 14. Dowdle 1,538 posts
- 15. #CARvsSF N/A
- 16. Niners 3,280 posts
- 17. Ji'Ayir Brown N/A
- 18. Roman Reigns 7,575 posts
- 19. Nick Scott N/A
- 20. Canales 9,133 posts
You might like
-
Johannes Czernin
@CzerninJohannes -
Clinical and Translational Imaging
@ClinTransImag -
Amir Iravani
@DrAIravani -
Jeremie Calais
@CalaisJeremie -
Ken Herrmann
@ProfKHerrmann -
Laura Evangelista
@EvangelistaI -
Matthias Eiber
@MatthiasEiber -
James Buteau
@ButeauJames -
Edel Noriega
@edel_noriega -
Majid Assadi MD,MSc(Adv.Onc.)
@AssadiMajidMD -
Laura Evangelista MD PhD
@lauraevangelis9 -
Julian G. Rojas
@julired3 -
IBA RadioPharma Solutions
@IBA_RadioPharma -
Rafael Fernandes Nunes
@RFNunesMD -
Carlos Artigas
@DrCArtigas
Something went wrong.
Something went wrong.